BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 9427882)

  • 1. Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis.
    Corey M; Edwards L; Levison H; Knowles M
    J Pediatr; 1997 Dec; 131(6):809-14. PubMed ID: 9427882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased rate of lung function decline in Australian adolescents with cystic fibrosis.
    Welsh L; Robertson CF; Ranganathan SC
    Pediatr Pulmonol; 2014 Sep; 49(9):873-7. PubMed ID: 24178906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth in prepubertal children with cystic fibrosis, homozygous for the Delta F508 mutation.
    Keller BM; Aebischer CC; Kraemer R; Schöni MH
    J Cyst Fibros; 2003 Jun; 2(2):76-83. PubMed ID: 15463854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective evaluation of resting energy expenditure, nutritional status, pulmonary function, and genotype in children with cystic fibrosis.
    Zemel BS; Kawchak DA; Cnaan A; Zhao H; Scanlin TF; Stallings VA
    Pediatr Res; 1996 Oct; 40(4):578-86. PubMed ID: 8888286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relation between genotype and phenotype in cystic fibrosis--analysis of the most common mutation (delta F508).
    Kerem E; Corey M; Kerem BS; Rommens J; Markiewicz D; Levison H; Tsui LC; Durie P
    N Engl J Med; 1990 Nov; 323(22):1517-22. PubMed ID: 2233932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical denouement and mutation analysis of patients with cystic fibrosis undergoing liver transplantation for biliary cirrhosis.
    Mack DR; Traystman MD; Colombo JL; Sammut PH; Kaufman SS; Vanderhoof JA; Antonson DL; Markin RS; Shaw BW; Langnas AN
    J Pediatr; 1995 Dec; 127(6):881-7. PubMed ID: 8523183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
    Walicka-Serzysko K; Sands D
    Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The decline and fall of pulmonary function in cystic fibrosis: new models, new lessons.
    Davis PB
    J Pediatr; 1997 Dec; 131(6):789-90. PubMed ID: 9427876
    [No Abstract]   [Full Text] [Related]  

  • 9. Endocrine and exocrine pancreatic function and the delta F508 mutation in cystic fibrosis.
    Lanng S; Schwartz M; Thorsteinsson B; Koch C
    Clin Genet; 1991 Nov; 40(5):345-8. PubMed ID: 1756609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cystic fibrosis mutation associated with mild lung disease.
    Gan KH; Veeze HJ; van den Ouweland AM; Halley DJ; Scheffer H; van der Hout A; Overbeek SE; de Jongste JC; Bakker W; Heijerman HG
    N Engl J Med; 1995 Jul; 333(2):95-9. PubMed ID: 7539891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of deterioration of lung function in cystic fibrosis.
    Schaedel C; de Monestrol I; Hjelte L; Johannesson M; Kornfält R; Lindblad A; Strandvik B; Wahlgren L; Holmberg L
    Pediatr Pulmonol; 2002 Jun; 33(6):483-91. PubMed ID: 12001283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severity of cystic fibrosis in patients homozygous and heterozygous for delta F508 mutation.
    Johansen HK; Nir M; Høiby N; Koch C; Schwartz M
    Lancet; 1991 Mar; 337(8742):631-4. PubMed ID: 1671990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal relationship between physical activity and lung health in patients with cystic fibrosis.
    Schneiderman JE; Wilkes DL; Atenafu EG; Nguyen T; Wells GD; Alarie N; Tullis E; Lands LC; Coates AL; Corey M; Ratjen F
    Eur Respir J; 2014 Mar; 43(3):817-23. PubMed ID: 24176992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation between phenotype and genotype in a group of patients with cystic fibrosis].
    Navarro H; Kolbach M; Repetto G; Guiraldes E; Harris P; Foradori A; Poggi H; Sánchez I
    Rev Med Chil; 2002 May; 130(5):475-81. PubMed ID: 12143267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung function decline in cystic fibrosis patients and timing for lung transplantation referral.
    Rosenbluth DB; Wilson K; Ferkol T; Schuster DP
    Chest; 2004 Aug; 126(2):412-9. PubMed ID: 15302726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Energy expenditure and genotype of children with cystic fibrosis.
    Tomezsko JL; Stallings VA; Kawchak DA; Goin JE; Diamond G; Scanlin TF
    Pediatr Res; 1994 Apr; 35(4 Pt 1):451-60. PubMed ID: 7519343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
    De Boeck K; Weren M; Proesmans M; Kerem E
    Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severity of chest disease in cystic fibrosis patients in relation to their genotypes.
    al-Jader LN; Meredith AL; Ryley HC; Cheadle JP; Maguire S; Owen G; Goodchild MC; Harper PS
    J Med Genet; 1992 Dec; 29(12):883-7. PubMed ID: 1479603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between genotype and phenotype in patients with cystic fibrosis.
    Cystic Fibrosis Genotype-Phenotype Consortium
    N Engl J Med; 1993 Oct; 329(18):1308-13. PubMed ID: 8166795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal assessment of lung function from infancy to childhood in patients with cystic fibrosis.
    Harrison AN; Regelmann WE; Zirbes JM; Milla CE
    Pediatr Pulmonol; 2009 Apr; 44(4):330-9. PubMed ID: 19274621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.